List of insiders holdings for X4 Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC ISALY SAMUEL D 10% Owner | 2024-02-14 19:36:59 | 11,494,437 0 | 11,494,437 | Form 13G |
Chang Carmen 10% Owner | 2018-07-17 16:28:34 | 0 2,000,000 | 2,000,000 | Form 3 |
Behbahani Ali 10% Owner | 2018-07-17 16:26:49 | 0 2,000,000 | 2,000,000 | Form 3 |
Viswanathan Ravi 10% Owner | 2017-11-20 16:28:01 | 0 2,000,000 | 2,000,000 | Form 3 |
Sonsini Peter W. 10% Owner | 2017-11-20 16:27:31 | 0 2,000,000 | 2,000,000 | Form 3 |
SANDELL SCOTT D 10% Owner | 2017-11-20 16:27:01 | 0 2,000,000 | 2,000,000 | Form 3 |
Sakoda Jon 10% Owner | 2017-11-20 16:26:33 | 0 2,000,000 | 2,000,000 | Form 3 |
Puttagunta Chetan 10% Owner | 2017-11-20 16:26:07 | 0 2,000,000 | 2,000,000 | Form 3 |
MOTT DAVID M 10% Owner | 2017-11-20 16:25:35 | 0 2,000,000 | 2,000,000 | Form 3 |
BARRIS PETER J 10% Owner | 2017-11-20 16:23:38 | 0 2,000,000 | 2,000,000 | Form 3 |
BASKETT FOREST 10% Owner | 2017-11-20 16:24:09 | 0 2,000,000 | 2,000,000 | Form 3 |
Florence Anthony A. Jr. 10% Owner | 2017-11-20 16:24:35 | 0 2,000,000 | 2,000,000 | Form 3 |
Makhzoumi Mohamad 10% Owner | 2017-11-20 16:25:05 | 0 2,000,000 | 2,000,000 | Form 3 |
Ragan Paula President and CEO | 2024-11-19 16:31:25 | 993,919 0 | 993,919 | Form 4 |
SVLSF V LLC SVLSF VI LLC SV Life Sciences Fund VI Strategic Partners L.P. SV Life Sciences Fund VI L.P. SV Life Sciences Fund V Strategic Partners L.P. SV LIFE SCIENCES FUND V LP 10% Owner | 2018-02-14 17:22:11 | 946,769 0 | 946,769 | Form 13D |
SVLSF V LLC SV Life Sciences Fund VI Strategic Partners L.P. SV Life Sciences Fund VI L.P. SV Life Sciences Fund V Strategic Partners L.P. SV LIFE SCIENCES FUND V LP 10% Owner | 2018-02-14 17:22:11 | 946,769 0 | 946,769 | Form 13D |
NeoMed Innovation V L.P. NeoMed Management (Jersey) Ltd NeoMed Innovation V Ltd 10% Owner | 2017-11-20 18:15:22 | 867,639 0 | 867,639 | Form 4 |
DiBiase Mary Chief Operating Officer | 2024-10-08 16:44:13 | 452,060 0 | 452,060 | Form 4 |
GV 2016 GP L.L.C. GV 2016 GP L.P. GV 2016 L.P. Alphabet Inc. 10% Owner | 2017-11-20 17:43:45 | 0 451,362 | 451,362 | Form 4 |
Section 32 Fund 1 LP Section 32 GP 1 LLC Maris William J 10% Owner | 2017-11-20 17:38:08 | 451,362 0 | 451,362 | Form 4 |
Taveras Arthur Chief Scientific Officer | 2024-10-08 16:44:02 | 388,026 0 | 388,026 | Form 4 |
EMBL Technology Fund II GmbH & Co. KG EMBL Ventures Verwaltungs GmbH Adams Jan Herr Stefan Muhlenbeck Frank 10% Owner | 2017-11-20 21:56:51 | 370,454 0 | 370,454 | Form 4 |
Polaris Venture Management Co. V L.L.C. Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. Flint Jonathan A 10% Owner | 2019-07-17 16:52:55 | 311,492 0 | 311,492 | Form 13D |
GRAY MICHAEL President, CEO and CFO | 2018-11-28 21:50:26 | 250,000 0 | 250,000 | Form 4 |
Alexandria Venture Investments LLC 10% Owner | 2017-11-20 10:01:01 | 225,680 0 | 225,680 | Form 4 |
Stewart Murray Director | 2024-06-11 16:13:02 | 191,504 0 | 191,504 | Form 4 |
Arbet-Engels Christophe Chief Medical Officer | 2024-02-28 17:52:37 | 180,816 0 | 180,816 | Form 4/A |
Meisner Derek M Chief Legal Officer | 2022-08-19 13:08:05 | 145,155 0 | 145,155 | Form 4 |
Woods Keith Director | 2024-06-11 16:12:38 | 135,000 0 | 135,000 | Form 4 |
Anna-Maria & Stephen Kellen Foundation Inc. 10% Owner | 2017-11-20 17:42:32 | 124,381 0 | 124,381 | Form 4 |
WYZGA MICHAEL S Director | 2024-06-11 16:12:12 | 121,667 0 | 121,667 | Form 4 |
Bill & Melinda Gates Foundation 10% Owner | 2019-03-15 16:36:25 | 120,363 0 | 120,363 | Form 13G |
Cadavid Diego Chief Medical Officer | 2022-03-01 16:08:48 | 104,107 0 | 104,107 | Form 4 |
Lawton Alison Frances Director | 2024-06-11 16:12:24 | 96,667 0 | 96,667 | Form 4 |
Bridger Gary Director | 2024-06-11 16:12:48 | 96,667 0 | 96,667 | Form 4 |
de Craecker Francoise Director | 2024-06-11 16:13:35 | 96,667 0 | 96,667 | Form 4 |
MCGIRR DAVID W J Director | 2024-06-11 16:13:13 | 96,667 0 | 96,667 | Form 4 |
Aliski William Director | 2024-06-11 16:13:25 | 96,667 0 | 96,667 | Form 4 |
BLECH ISAAC Director | 2019-04-02 20:02:00 | 77,650 0 | 77,650 | Form 4/A |
Mantus David Chief Development Officer | 2018-03-09 16:37:55 | 50,000 0 | 50,000 | Form 4 |
STEVENS ANTHONY CHRIS Chief Medical Officer | 2018-03-09 16:32:58 | 50,000 0 | 50,000 | Form 4 |
Baldry Mark Chief Commercial Officer | 2024-10-08 16:44:32 | 48,509 0 | 48,509 | Form 4 |
Nagy Eszter Chief Scientific Officer | 2018-03-09 16:36:08 | 45,000 0 | 45,000 | Form 4 |
Skerlj Renato Chief Scientific Officer | 2020-09-10 08:36:45 | 42,076 0 | 42,076 | Form 4 |
Kelley Lynne E Chief Medical Officer | 2019-04-26 19:58:35 | 37,170 0 | 37,170 | Form 4 |
Nessi Claudio Director | 2018-06-07 16:23:15 | 10,000 0 | 10,000 | Form 4 |
MCGUIRE TERRANCE Director | 2018-06-07 17:07:21 | 10,000 0 | 10,000 | Form 4 |
Clark William D Director | 2018-06-07 16:17:58 | 10,000 0 | 10,000 | Form 4 |
Gerngross Tillman U. Director | 2018-06-07 16:19:46 | 10,000 0 | 10,000 | Form 4 |
GORDON CARL L Director | 2018-06-07 16:21:08 | 10,000 0 | 10,000 | Form 4 |
Ross Michael Jay Director | 2018-06-07 16:23:51 | 10,000 0 | 10,000 | Form 4 |
SCHULMAN AMY W Director | 2018-06-07 16:24:54 | 10,000 0 | 10,000 | Form 4 |
Russo Rene Director | 2021-06-02 16:57:51 | 6,000 0 | 6,000 | Form 4 |
Mostafa Adam S. Chief Financial Officer | 2024-10-08 16:44:42 | 0 0 | 0 | Form 4 |
New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 2019-05-28 16:53:05 | 0 0 | 0 | Form 13D |